ABSTRACT
INTRODUCTION

1
Mitochondria are complex organelles involved in a plethora of vital cellular functions including energy Second Region of Homology (SRH) domain 11 , and Zn 2+ metalloprotease C-terminal domain 7, 11 . The N-termini of the other AAA+ proteins. These domains mediate hexamerization of Yme1, thereby forming the 1 central pore structure of the complex that leads a target protein to the complex's catalytic chamber 7 
9
Note that the AAA+ and metalloprotease modules are not color-highlighted in top and bottom view projections, 7 that i-AAA can perform chaperone-like functions both in vitro 25 and in vivo 26, 27 . At present, Yme1 appears to 
10
does not seem to recognize them in a folded state 29 . Only when an unfolded degron is recognized, the i-AAA
11
can subsequently unfurl the rest of the protein and proteolyze it in a processive manner. This is achieved by 12 active unfolding and feeding of the substrate into the enzyme's catalytic chamber through the complex's central 13 pore using the energy of ATP hydrolysis 28 .
14
In line with the functional versatility of Yme1 are its multifaceted activities within the mitochondria -
15
the i-AAA has been implicated in a variety of processes including regulation of mitochondrial fission/fusion mechanism by processing the IM GTPase OPA1 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 The matrix-facing m-AAA protease has been originally described in yeast as a hetero Biochemistry   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
20
The molecular architecture of m-AAA appears to be similar to that of the i-AAA protease 7, 39 
19
FUNCTIONAL INTERACTIONS OF THE IM METALLOPEPTIDASES
20
Functional interactions between the IM proteases can manifest in various forms including: (1) 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 exemplified by versatile functional interactions between Oma1 and i-AAA proteases. The following text will 1 discuss some of these activities.
2
The study by Rainbolt et 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 the enzyme, S-OPA1, which facilitates partitioning of the mitochondrial network. The i-AAA protease appears 
10
Another well-characterized shared substrate of the IM metallopeptidases is mammalian dynamin-related 
20
assembled EMRE also appears to be the substrate of m-AAA, however its cleavage seems to be independent of 21 its association with MAIP1 81 .
22
The i-AAA protease is also known to be a part of supramolecular asemblies regulating its proteolytic 
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[58] Almajan, E. R., Richter, R., Paeger, L., Martinelli, P., Barth, E., Decker, T., Larsson, N. G., Kloppenburg, P., Langer, T., and Rugarli, E. I. (2012) 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 For 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57 58 59 (red) and an AAA+ domain (blue) modeled by fitting the crystal structure of the FtsH protease from Thermogota maritima (3KDS) into the cryoEM envelope from S. cerevisiae m-AAA enzyme (EMD-1712). The IMSD domain (orange) in the distal part is presented by the solution structure of a portion of human AFG3L2 (2LNA). Note that the AAA+ and metalloprotease modules are not color-highlighted in top and bottom view projections, respectively, for better clarity. The model was generated using the ChimeraX software. (B) i-AAA protease forms a homo-hexameric complex with the catalytic M41 zinc metalloprotease's domain (purple) and the AAA+ ATPase domain (yellow) facing the IMS, which are then followed by the transmembrane spans and the Yme1-specific N-terminus (orange). The enzyme is able to: (1) proteolytically process soluble, IMS-residing substrates, presumably without engaging its AAA+ module; (2) extract and degrade IM-anchored proteins through the concerted action of the ATPase and proteolytic domains; or (3) merely unfold/refold them via its AAA+ module, thus functioning as a chaperone. Various substrates have
Page 31 of 33 Biochemistry   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 been identified for both mammalian and yeast iAAA proteases, which however, in many cases are not orthologous. The insets in panels B and C list proteins that have been experimentally confirmed as bona fide substrates of each respective protease. The asterisks or ts (temperature sensitive) acronyms denote proteins that are perceived as substrates upon a condition when they are damaged, unassembled, and/or misfolded. OM, outer mitochondrial membrane; IM, inner mitochondrial membrane; IMS, intermembrane space. (C) m-AAA proteases can form either homo-or hetero-oligomeric complexes with their proteolytic (red, pink) and ATPase (blue, dark purple) domains exposed to the matrix. Similar to the i-AAA enzyme, the m-AAA proteases demonstrate remarkable versatility in their substrate processing modes. Likewise, the m-AAA substrates appear to differ between mammalian and yeast systems. More details can be found in the text.
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Page 32 of 33 Biochemistry   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57 58 59 The enzyme comprises the IMS-facing proteolytic domain (grey; the position of the HExxH catalytic motif is highlighted in purple), the transmembrane segment (teal), and a shorter N-terminal α helix that likely helps to further stabilize the enzyme's association with the IM (navy). The N-terminal moiety of vertebrate Oma1 orthologs also contains a stretch of charged amino acid residues that has been proposed to participate in stress-induced activation of the enzyme. (B) Predicted structural model of the yeast Oma1 protease. The model was produced using the iTASSER prediction software and further processed using the ChimeraX. (C) OMA1 exists as a largely dormant, homo-oligomeric complex that is activated upon indicated homeostatic insults. While the exact mechanism behind this process remains to be clarified, changes in conformation of the Oma1 oligomer were proposed to trigger the enzyme's activation. The inset shows currently known substrates of Oma1. The yeast Cox1 protein (marked with the asterisk) is degraded by Oma1 in a subset of cytochrome oxidase assembly mutants. Similarly, Oma1 appears to specifically degrade Page 33 of 33 Biochemistry   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 temperature sensitive (ts), misfolding-prone variants of the IM translocase Oxa1 and phosphatidylserine decarboxylase Psd1. More details are available in the text.
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Page 34 of 33 Biochemistry   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Figure 3. Functional cooperation between the i-AAA and OMA1 proteases. (A) OMA1 is activated by conditions of mitochondrial stress. Original reports suggested that the activated protease undergoes autoproteolysis (1), thereby eliminating over-reactive enzyme when the stressed condition is over. However, a recent report proposed an alternative model, wherein the i-AAA is responsible for degradation of stressactivated OMA1 (2) . Reciprocally, OMA1 may be involved in proteolytic cleavage of YME1L when mitochondrial ATP levels are attenuated (3). (B) Metalloproteases YME1L and OMA1 cooperate in proteolytic processing of long forms of GTPase OPA1 (L-OPA1). This variant is important for mitochondrial fusion and normal cristae ultrastructure. L-OPA1 forms harbor two physically separate cleavage sites, S1 and S2, which are recognized by OMA1 and YME1L, respectively. Cleavage of L-OPA by either protease yields short forms of the enzyme, S-OPA1, which facilitates partitioning of the mitochondrial network. The i-AAA protease appears to be the key enzyme mediating L-OPA1 processing under non-stress conditions, yielding nearly equimolar amounts of L-OPA1 and S-OPA1 and thus balances fusion and fission of the mitochondrial network. OMA1 exhibits little or no 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 involvement in L-OPA1 processing under non-stress conditions. Homeostatic challenges or mitochondrial dysfunction trigger stress-activation of OMA1, which mediates rapid processing of the entire L-OPA1 pool into S-OPA1 forms, thereby stimulating mitochondrial fission and massive fragmentation of the mitochondrial network. Further details can be found in the text. Representative confocal fluorescent images show MitoTracker Red-stained mitochondrial network in cultured SH-SY5Y neurobalstoma cells that have been challenged or not with an uncoupler CCCP.
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